SCHEMBL3846602

SCHEMBL3846602

CN(c1ccccc1)S(=O)(=O)c1ccc(-c2ncnc3ccc(Br)cc23)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.44
LMNA P02545 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PIK3CD O00329 1/20 0.44
PIK3R1 P27986 1/20 0.44
HIF1A Q16665 1/20 0.44
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 4/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
ALDH1A1 P00352 3/20 0.39
ITGB1 P05556 1/20 0.38
ITGA2 P17301 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
EGFR P00533 3/20 0.37
CSF1R P07333 3/20 0.37
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849639 0.87 MAPT (0.42) HTTLMNASMN1; SMN2PIK3CDPIK3R1
SCHEMBL3847250 0.82 HTT (0.43) HTTLMNASMN1; SMN2PIK3CDPIK3R1
SCHEMBL3845623 0.81 SMN1; SMN2 (0.44) HTTLMNASMN1; SMN2PIK3CDPIK3R1
SCHEMBL3847128 0.79 SMN1; SMN2 (0.44) HTTLMNASMN1; SMN2TP53MAPT
SCHEMBL3851528 0.79 SMN1; SMN2 (0.47) HTTLMNASMN1; SMN2TP53MAPT
SCHEMBL3846909 0.78 SMN1; SMN2 (0.41) HTTLMNASMN1; SMN2TP53MAPT
Hydrochloric Acid SCHEMBL3854051 0.77 KIT (0.36) LMNAPIK3CDHIF1ATP53MAPT
SCHEMBL13874127 0.75 SMN1; SMN2 (0.41) HTTLMNASMN1; SMN2MAPTKMT2A
SCHEMBL3850966 0.73 KIT (0.34) LMNAPIK3CDTP53MAPTNPC1
SCHEMBL3846413 0.73 SMN1; SMN2 (0.42) HTTLMNASMN1; SMN2PIK3CDPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed